Literature DB >> 15967267

The distribution of sensory fibers immunoreactive for the TRPV1 (capsaicin) receptor in the human prostate.

Paulo Dinis1, Ana Charrua, António Avelino, Istvan Nagy, José Quintas, Ulisses Ribau, Francisco Cruz.   

Abstract

OBJECTIVES: To determine the distribution of sensory fibers immunoreactive to the pain receptor TRPV1 in the human prostate.
METHODS: Eight prostates were harvested from cadaver transplant donors and immediately immersion fixed. Longitudinal and transverse 20 microm sections were cut on a cryostat and immunoreacted with two anti-human TPRV1 antibodies.
RESULTS: TRPV1-immunoreactive nerve fibers were distributed throughout the prostatic urethral mucosa, verumontanum, ejaculatory ducts and periurethral prostatic acini. In the urethral mucosa, TRPV1-immunoreactive fibers penetrated the epithelial layer up to its surface. In the transitional and peripheral zones of the gland no TRPV1-immunoreactive nerve fibers were detected.
CONCLUSIONS: The existence of a rich TRPV1 sensory innervation in the human prostate may open new therapeutic perspectives for the treatment of pain in patients with chronic prostatitis (Chronic Pelvic Pain Syndrome).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15967267     DOI: 10.1016/j.eururo.2005.01.009

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  16 in total

Review 1.  Botulinum A toxin for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms.

Authors:  Catherine A Thomas; Yao-Chi Chuang; Antonella Giannantoni; Michael B Chancellor
Journal:  Curr Urol Rep       Date:  2006-07       Impact factor: 3.092

Review 2.  TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications.

Authors:  António Avelino; Francisco Cruz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-24       Impact factor: 3.000

Review 3.  Transient receptor potential ion channels in primary sensory neurons as targets for novel analgesics.

Authors:  J Sousa-Valente; A P Andreou; L Urban; I Nagy
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

4.  TRP family proteins in the lower urinary tract: translating basic science into new clinical prospective.

Authors:  Massimo Lazzeri; Elisabetta Costantini; Massimo Porena
Journal:  Ther Adv Urol       Date:  2009-04

Review 5.  Small molecule vanilloid TRPV1 receptor antagonists approaching drug status: can they live up to the expectations?

Authors:  Arpad Szallasi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-06-14       Impact factor: 3.000

6.  Transurethral intraprostatic Botulinum toxin-A injection: a novel treatment for BPH refractory to current medical therapy in poor surgical candidates.

Authors:  Ali Hamidi Madani; Ahmad Enshaei; Abtin Heidarzadeh; Gholamreza Mokhtari; Alireza Farzan; Mani Mohiti Asli; Samaneh Esmaeili
Journal:  World J Urol       Date:  2012-03-13       Impact factor: 4.226

Review 7.  Transient receptor potential channels in sensory mechanisms of the lower urinary tract.

Authors:  Matthias Vanneste; Andrei Segal; Thomas Voets; Wouter Everaerts
Journal:  Nat Rev Urol       Date:  2021-02-03       Impact factor: 14.432

Review 8.  Hitting below the belt (bladder): botulinum treatment of urethral and prostate disorders.

Authors:  H Henry Lai; Christopher P Smith
Journal:  Curr Urol Rep       Date:  2007-09       Impact factor: 3.092

9.  Differential localizations of the transient receptor potential channels TRPV4 and TRPV1 in the mouse urinary bladder.

Authors:  Takahiro Yamada; Shinya Ugawa; Takashi Ueda; Yusuke Ishida; Kenji Kajita; Shoichi Shimada
Journal:  J Histochem Cytochem       Date:  2008-11-24       Impact factor: 2.479

10.  Expression of apoptosis-regulating genes in the rat prostate following botulinum toxin type A injection.

Authors:  Tiago Gorgal; Ana Charrua; João F Silva; António Avelino; Paulo Dinis; Francisco Cruz
Journal:  BMC Urol       Date:  2012-01-04       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.